{"Symbol": "EW", "AssetType": "Common Stock", "Name": "Edwards Lifesciences Corporation", "Description": "Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.", "CIK": "1099800", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES", "Address": "ONE EDWARDS WAY, IRVINE, CA, US", "FiscalYearEnd": "December", "LatestQuarter": "2021-09-30", "MarketCapitalization": "73065808000", "EBITDA": "1718600000", "PERatio": "50.34", "PEGRatio": "2.586", "BookValue": "8.88", "DividendPerShare": "None", "DividendYield": "0", "EPS": "2.325", "RevenuePerShareTTM": "8.18", "ProfitMargin": "0.29", "OperatingMarginTTM": "0.311", "ReturnOnAssetsTTM": "0.132", "ReturnOnEquityTTM": "0.303", "RevenueTTM": "5094500000", "GrossProfitTTM": "3305700000", "DilutedEPSTTM": "2.325", "QuarterlyEarningsGrowthYOY": "0.038", "QuarterlyRevenueGrowthYOY": "0.148", "AnalystTargetPrice": "120.65", "TrailingPE": "50.34", "ForwardPE": "46.51", "PriceToSalesRatioTTM": "14.34", "PriceToBookRatio": "13.33", "EVToRevenue": "14.29", "EVToEBITDA": "54.52", "Beta": "1.006", "52WeekHigh": "123.27", "52WeekLow": "78.44", "50DayMovingAverage": "115.73", "200DayMovingAverage": "102.26", "SharesOutstanding": "624334000", "DividendDate": "None", "ExDividendDate": "None"}